Multidrug-resistant bacteria detection in patients undergoing allogeneic hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
| dc.contributor.author | Brissot, Éolia | |
| dc.contributor.author | Villate, Alban | |
| dc.contributor.author | Alsuliman, Tamim | |
| dc.contributor.author | Beauvais, David | |
| dc.contributor.author | Bonnin, Agnès | |
| dc.contributor.author | Méar, Jean Baptiste | |
| dc.contributor.author | Souchet, Laëtitia | |
| dc.contributor.author | Yakoub-Agha, Ibrahim | |
| dc.contributor.author | Bazarbachi, Ali Abdul Hamid | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:57:12Z | |
| dc.date.available | 2025-01-24T11:57:12Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organizes annual workshops in the attempt to harmonize clinical practices among different francophone transplantation centers. Here we report our recommendations regarding detection of the multidrug-resistant bacteria in hematology. © 2020 Société Française du Cancer | |
| dc.identifier.doi | https://doi.org/10.1016/j.bulcan.2019.09.006 | |
| dc.identifier.uri | http://hdl.handle.net/10938/31284 | |
| dc.language.iso | en | |
| dc.publisher | John Libbey Eurotext | |
| dc.source | Scopus | |
| dc.subject | Allogeneic stem cell transplantation | |
| dc.subject | Multidrug-resistant bacteria | |
| dc.subject | Allografts | |
| dc.subject | Bacteria | |
| dc.subject | Bacterial infections | |
| dc.subject | Carrier state | |
| dc.subject | Cross infection | |
| dc.subject | Disease susceptibility | |
| dc.subject | Drug resistance, multiple, bacterial | |
| dc.subject | Hematologic neoplasms | |
| dc.subject | Hematopoietic stem cell transplantation | |
| dc.subject | Humans | |
| dc.subject | Risk | |
| dc.subject | Transplant recipients | |
| dc.subject | Adult | |
| dc.subject | Allogeneic hematopoietic stem cell transplantation | |
| dc.subject | Bone marrow transplantation | |
| dc.subject | Hematology | |
| dc.subject | Human | |
| dc.subject | Human tissue | |
| dc.subject | Practice guideline | |
| dc.subject | Review | |
| dc.subject | Allograft | |
| dc.subject | Bacterial infection | |
| dc.subject | Bacterium | |
| dc.subject | Consensus development | |
| dc.subject | Disease predisposition | |
| dc.subject | Drug effect | |
| dc.subject | Graft recipient | |
| dc.subject | Hematologic disease | |
| dc.subject | Heterozygote | |
| dc.subject | Isolation and purification | |
| dc.subject | Microbiology | |
| dc.subject | Multidrug resistance | |
| dc.title | Multidrug-resistant bacteria detection in patients undergoing allogeneic hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) | |
| dc.type | Review |
Files
Original bundle
1 - 1 of 1